For example, researchers found causation between mutations in IDH1, IDH2 and TET2—which negatively affect DNA hydroxymethylation rates—and CIMP in leukemia [42], gliomas [29] and several other cancer types [35]. This evidence concerns the gene IDH1 and cancer.